Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INSULET CORP
Report date April 28, 2025 · Filed April 30, 2025
Section 16 reporting ended · disclosed 2025-04-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,247 |
Reported balance
After 2025-04-28 transaction · row 1
1 source rowRow 1 · 2025-04-28 · Tax withholding · Disposed 3,587 · Balance 61,247 F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.
RESMED INC
Report date June 30, 2022 · Filed August 18, 2022
Section 16 reporting ended · disclosed 2022-08-18. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2019 Filed Jun 4, 2019 20:18 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-020711 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 01, 2019 Filed May 3, 2019 23:23 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-017358 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,638 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 01, 2019 Filed May 3, 2019 23:23 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $104.51 | $83,608.00 |
DisclosureSEC source: 0001127602-19-017358 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,857 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 01, 2019 Filed May 3, 2019 23:23 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $104.51 | $83,608.00 |
DisclosureSEC source: 0001127602-19-017358 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,657 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 01, 2019 Filed May 3, 2019 23:23 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-017358 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 14:50 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-014404 · form4.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,438 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 14:50 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $104.96 | $83,968.00 |
DisclosureSEC source: 0001127602-19-014404 · form4.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,657 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 14:50 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $104.96 | $83,968.00 |
DisclosureSEC source: 0001127602-19-014404 · form4.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,457 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 14:50 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001127602-19-014404 · form4.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 15:07 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001567619-19-005879 · doc1.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,238 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 15:07 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $102.80 | $82,240.00 |
DisclosureSEC source: 0001567619-19-005879 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,457 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 15:07 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $102.80 | $82,240.00 |
DisclosureSEC source: 0001567619-19-005879 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,257 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 15:07 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001567619-19-005879 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 18:45 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 832 | $100.45 | $83,574.40 |
DisclosureSEC source: 0001567619-19-004790 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,257 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 2/16/2017. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 17:37 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001567619-19-002214 · doc1.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,038 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 17:37 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $95.09 | $76,072.00 |
DisclosureSEC source: 0001567619-19-002214 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,089 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 17:37 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $95.09 | $76,072.00 |
DisclosureSEC source: 0001567619-19-002214 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,889 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 17:37 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001567619-19-002214 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:04 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 800 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001567619-19-000256 · doc1.xml · derivative · entry 4 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,838 Underlying: ResMed Commmon Stock · 800 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:04 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $112.13 | $89,704.00 |
DisclosureSEC source: 0001567619-19-000256 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,889 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:04 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 800 | $112.13 | $89,704.00 |
DisclosureSEC source: 0001567619-19-000256 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,689 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:04 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 800 | $58.24 | $46,592.00 |
DisclosureSEC source: 0001567619-19-000256 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 17:11 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $112.09 | $67,254.00 |
DisclosureSEC source: 0001567619-18-007389 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,689 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 30, 2018 Filed Dec 3, 2018 17:07 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResmed Stock Option Plan · Derivative | 9,168 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001567619-18-007208 · doc1.xml · derivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Commmon Stock · 9,168 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 annually on the grant anniversary. Read SEC document |
| November 30, 2018 Filed Dec 3, 2018 17:07 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 9,168 | $43.63 | $399,999.84 |
DisclosureSEC source: 0001567619-18-007208 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2018 Filed Nov 27, 2018 22:45 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,893 | $105.52 | $621,829.36 |
DisclosureSEC source: 0001567619-18-007000 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,121 F1 · price: This transaction was executed in multiple trades at prices ranging from $105.30 to $105.80. The price reported above reflects the weighted average sale price. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 22:36 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 16,071 | $104.18 | $1,674,276.78 |
DisclosureSEC source: 0001567619-18-006938 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,014 F2 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 22:36 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 28,810 | $104.18 | $3,001,425.80 |
DisclosureSEC source: 0001567619-18-006938 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,085 F1 · shares: Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on November 21, 2018, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 22:57 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,398 | $106.94 | $256,442.12 |
DisclosureSEC source: 0001567619-18-005880 · doc1.xml · nonDerivative · entry 3 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,275 F4 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 22:57 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,125 | $106.94 | $120,307.50 |
DisclosureSEC source: 0001567619-18-005880 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,673 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 22:57 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,587 | $106.94 | $169,713.78 |
DisclosureSEC source: 0001567619-18-005880 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,798 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. F2 · balance_after: Includes 80.49 shares of ResMed stock purchased on October 31, 2018, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 20:11 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $105.93 | $63,558.00 |
DisclosureSEC source: 0001567619-18-005009 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,304 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. F1 · price: The transaction was conducted under a Rule 10b5-1 Plan. F1 · balance_after: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 21:53 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 3,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-004797 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,904 F1 · shares: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on October 29, 2018, when the compensation committee certified that the performance metrics were met. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:59 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $115.88 | $69,528.00 |
DisclosureSEC source: 0001567619-18-003661 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,623 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. F1 · price: The transaction was conducted under a Rule 10b5-1 Plan. F1 · balance_after: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 17:58 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $111.59 | $66,954.00 |
DisclosureSEC source: 0001567619-18-002119 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,223 F1 · kind: The transaction was conducted under a Rule 10b5-1 Plan. F1 · price: The transaction was conducted under a Rule 10b5-1 Plan. F1 · balance_after: The transaction was conducted under a Rule 10b5-1 Plan. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 16:50 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 12,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-001350 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,823 F1 · shares: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on August 15, 2018, when the compensation committee certified that the performance metrics were met. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:29 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $105.93 | $63,558.00 |
DisclosureSEC source: 0001140361-18-035061 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,663 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. F1 · price: The transaction was conducted under a Rule10b5-1 Plan. F1 · balance_after: The transaction was conducted under a Rule10b5-1 Plan. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 19:28 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $102.80 | $61,680.00 |
DisclosureSEC source: 0001140361-18-031231 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,263 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. F1 · price: The transaction was conducted under a Rule10b5-1 Plan. F1 · balance_after: The transaction was conducted under a Rule10b5-1 Plan. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:20 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $102.80 | $61,680.00 |
DisclosureSEC source: 0001140361-18-027078 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,863 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. F1 · price: The transaction was conducted under a Rule10b5-1 Plan. F2 · balance_after: Includes 202 shares of ResMed stock purchased on April 30, 2018, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| May 01, 2018 Filed May 2, 2018 16:45 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $94.69 | $56,814.00 |
DisclosureSEC source: 0001140361-18-021149 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,261 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. F1 · price: The transaction was conducted under a Rule10b5-1 Plan. Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 17:08 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-019219 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,861 F1 · shares: Represents performance-based restricted stock units granted on February 16, 2017. The shares were earned on April 19, 2018, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 01:09 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $98.19 | $58,914.00 |
DisclosureSEC source: 0001140361-18-016905 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,940 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. F1 · price: The transaction was conducted under a Rule10b5-1 Plan. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 20:21 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $94.01 | $56,406.00 |
DisclosureSEC source: 0001140361-18-011568 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,540 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 18:19 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 862 | $93.81 | $80,864.22 |
DisclosureSEC source: 0001140361-18-009258 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,140 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 2/16/2017. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 18:01 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $100.11 | $60,066.00 |
DisclosureSEC source: 0001140361-18-004935 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,002 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $100.10 to $100.18. The price reported above reflects the weighted average sale price. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:55 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 600 | $84.96 | $50,976.00 |
DisclosureSEC source: 0001140361-18-000686 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,602 F1 · kind: The transaction was conducted under a Rule10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.93 to $84.98. The price reported above reflects the weighted average sale price. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 01:44 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 4,161 | $84.63 | $352,145.43 |
DisclosureSEC source: 0001140361-17-044037 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,202 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 01:44 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 7,973 | $84.63 | $674,754.99 |
DisclosureSEC source: 0001140361-17-044037 · doc1.xml · nonDerivative · entry 1 Hollingshead James · CIK 0001570610 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,363 F1 · kind: Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted November 19, 2014, with a three-year performance period. The shares were earned and vested November 27, 2017, when the ResMed compensation committee certified performance. F2 · shares: Shares earned based on performance at 57% of the target award. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 15:48 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 7,019 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001140361-17-043629 · doc1.xml · derivative · entry 3 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Commmon Stock · 7,019 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 annually each November 11. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 15:48 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 7,019 | $84.16 | $590,719.04 |
DisclosureSEC source: 0001140361-17-043629 · doc1.xml · nonDerivative · entry 2 Hollingshead James · CIK 0001570610 · President, Sleep Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,390 F1 · price: This transaction was executed in multiple trades at prices ranging from $83.74 to $84.53. The price reported above reflects the weighted average sale price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.